Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

JAMA Oncology

Topics

Medicine

Cancer Oncology

Immunology

Internal Medicine

Urology

Show all topics

DOI

10.1001/jamaoncol.2018.2168